Cover Image
市場調查報告書

全球醫療用生物感應器市場

Global Medical Biosensors Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 240774
出版日期 內容資訊 英文 92 Pages
訂單完成後即時交付
價格
Back to Top
全球醫療用生物感應器市場 Global Medical Biosensors Market 2014-2018
出版日期: 2014年07月23日 內容資訊: 英文 92 Pages
簡介

醫療用生物感應器,借物理化學性偵測設備的力量分析生物成分趨勢。這樣的設備,採用侵入性/非侵入性的手法,監測患者的健康狀態和疾病的改善情形,治療結果狀況等。這些具成本效益也容易使用,且在患者診斷中控制錯誤在最小限度進行標準化。主要用途為,膽固醇和病原體的偵測,肌肉的替代,腦脊髓的偵測等。還有在提高患者的QoL(生活品質)上發揮重要作用。全球醫療用生物感應器市場,預計從2013年到2018年,以年複合成長率(CAGR)10.16%擴大。

本報告提供全球醫療用生物感應器市場概要、結構和市場趨勢(今後5年的預測值)、各地區的詳細趨勢、推動、阻礙市場要素與其影響力,再加上主要企業簡介、今後的市場機會等調查、考察。

第1章 摘要整理

第2章 簡稱集

第3章 分析範圍

  • 市場概要
  • 主要的產品

第4章 市場分析技術

  • 市場分析的流程
  • 分析方法

第5章 簡介

第6章 市場環境

  • 市場概況
  • 市場規模與其預測
  • 波特的五力分析

第7章 各用途的詳細分析

  • 全球血糖監測系統市場
    • 市場規模與其預測
  • 全球膽固醇、監測市場
  • 全球傳染病檢查市場
  • 全球心臟生物標記檢驗市場
  • 全球血氣檢驗市場
  • 全球妊娠檢驗市場

第8章 各技術的詳細分析

  • 電子化學生物感應器
  • 光學式生物感應器
  • 壓電方式生物感應器

第9章 各終端用戶的詳細分析

  • POC(重點照護)用檢查裝置市場
  • 家用診斷設備市場
  • 研究開發用設備市場

第10章 各地區的分析

  • 南北美洲的醫療用生物感應器市場
  • 歐非中東(EMEA)地區的醫療用生物感應器市場
  • 亞太地區(APAC)地區的醫療用生物感應器市場

第11章 購買標準

第12章 市場發展要素

第13章 成長要素與其影響

第14章 市場課題

第15章 發展要素與課題的影響

第16章 市場趨勢

第17章 市場趨勢與其影響

第18章 供應商環境

  • 競爭方案
    • 近幾年的主要趨勢
  • 市場佔有率分析
  • 其他著名的供應商
  • Abbott Laboratories
    • 產業概要
    • 產業結構
    • 各部門的銷售額
    • 各地區的銷售額
    • 主要資料
    • SWOT分析
  • Bayer HealthCare
  • LifeScan
  • F. Hoffmann-La Roche

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR3888

About Global Medical Biosensors

Medical biosensors are used to analyze biological components with the help of physicochemical detectors. These biosensors monitor health status, disease betterment, and therapeutic treatment outcomes through invasive and non-invasive methods. They are cost-effective and user-friendly devices. Also, they are standardized to minimize errors during the diagnosis of patients. Medical biosensors are mostly used in cholesterol detection, pathogen detection, muscle displacement, and cerebrospinal detection. Medical biosensors play a major role in improving patients' quality of life.

TechNavio's analysts forecast the Global Medical Biosensors market to grow at a CAGR of 10.16 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Medical Biosensors market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various medical biosensors, based on their application such as:

  • Blood glucose testing
  • Cholesterol testing
  • Infectious disease testing
  • Cardiac biomarkers testing
  • Blood gas testing
  • Pregnancy testing
  • Others (such as cancer biomarkers, electrolyte analyzers, blood coagulation testing, tumor markers, and urinalysis testing)

TechNavio's report, the Global Medical Biosensors market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Medical Biosensors Platform market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Abbott Laboratories
  • Bayer HealthCare AG
  • LifeScan Inc.
  • F. Hoffmann-La Roche Ltd.

Other Prominent Vendors

  • Acethem
  • Acon
  • Biotest Medical
  • FICO
  • Contec Medical
  • Convergent
  • Integrity
  • I-sens
  • Nipro Diagnostics
  • Optiscan
  • TaiDoc
  • Urit Medical

Market Driver

  • Increase in Technological Innovations

For a full, detailed list, view our report

Market Challenge

  • Advances in Technology

For a full, detailed list, view our report

Market Trend

  • Expanding Economies in the APAC Region

For a full, detailed list, view our report

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Application

  • 07.1. Global Blood Glucose Testing Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global Cholesterol Testing Market
    • 07.2.1. Market Size and Forecast
  • 07.3. Global Infectious Disease Testing Market
    • 07.3.1. Market Size and Forecast
  • 07.4. Global Cardiac Biomarkers Testing Market
    • 07.4.1. Market Size and Forecast
  • 07.5. Global Blood Gas Testing Market
    • 07.5.1. Market Size and Forecast
      • Global Pregnancy Testing Market
    • 07.5.2. Market Size and Forecast

08. Market Segmentation by Technology

  • 08.1. Electrochemical Biosensors
  • 08.2. Optical Biosensors
  • 08.3. Piezoelectric Biosensors

09. Market Segmentation by End-user

  • 09.1. Global Point-of-Care Testing Market
    • 09.1.1. Market Size and Forecast
  • 09.2. Global Home Diagnostics Market
    • 09.2.1. Market Size and Forecast
  • 09.3. Global Research Laboratories Market
    • 09.3.1. Market Size and Forecast

10. Geographical Segmentation

  • 10.1. Medical Biosensors Market in the Americas
    • 10.1.1. Market Size and Forecast
  • 10.2. Medical Biosensors Market in the EMEA Region
    • 10.2.1. Market Size and Forecast
  • 10.3. Medical Biosensors Market in the APAC Region
    • 10.3.1. Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
  • 18.2. Market Share Analysis 2013
  • 18.3. Other Prominent Vendors
  • 18.4. Abbott Laboratories
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation by Revenue 2012
    • 18.4.4. Business Segmentation by Revenue 2011 and 2012
    • 18.4.5. Geographical Segmentation by Revenue 2012
    • 18.4.6. Business Strategy
    • 18.4.7. Key Information
    • 18.4.8. SWOT Analysis
    • 18.4.9. Strengths
    • 18.4.10. Weakness
    • 18.4.11. Opportunities
    • 18.4.12. Threats
  • 18.5. Bayer HealthCare
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Business Segmentation by Revenue 2013
    • 18.5.4. Business Segmentation by Revenue 2012 and 2013
    • 18.5.5. Geographical Segmentation by Revenue 2013
    • 18.5.6. Business Strategy
    • 18.5.7. Recent Developments
    • 18.5.8. SWOT Analysis
    • 18.5.9. Strengths
    • 18.5.10. Weaknesses
    • 18.5.11. Opportunities
    • 18.5.12. Threats
  • 18.6. LifeScan
    • 18.6.1. Key Facts
    • 18.6.2. Business Overview
    • 18.6.3. Product Segmentation
    • 18.6.4. Geographical Segmentation by Revenue 2013
    • 18.6.5. Business Strategy
    • 18.6.6. Recent Developments
    • 18.6.7. SWOT Analysis
    • 18.6.8. Strengths
    • 18.6.9. Weaknesses
    • 18.6.10. Opportunities
    • 18.6.11. Threats
  • 18.7. F. Hoffmann-La Roche
    • 18.7.1. Key Facts
    • 18.7.2. Business Overview
    • 18.7.3. Business Segmentation by Revenue 2013
    • 18.7.4. Business Segmentation by Revenue 2012 and 2013
    • 18.7.5. Geographical Segmentation by Revenue 2013
    • 18.7.6. Business Strategy
    • 18.7.7. Recent Developments
    • 18.7.8. SWOT Analysis
    • 18.7.9. Strengths
    • 18.7.10. Weaknesses
    • 18.7.11. Opportunities
    • 18.7.12. Threats

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Medical Biosensors Market 2013-2018 (US$ million)
  • Exhibit 3: Global Medical Biosensors Market Segmentation by Application
  • Exhibit 4: Global Medical Biosensors Segmentation Market by Application 2013
  • Exhibit 5: Global Blood Glucose Testing Market 2013-2018 (US$ million)
  • Exhibit 6: Global Cholesterol Testing Market 2013-2018 (US$ million)
  • Exhibit 7: Global Infectious Disease Testing Market 2013-2018 (US$ million)
  • Exhibit 8: Global Cardiac Biomarkers Testing Market 2013-2018 (US$ million)
  • Exhibit 9: Global Blood Gas Analyzers Market 2013-2018 (US$ million)
  • Exhibit 10: Global Pregnancy Testing Market 2013-2018 (US$ million)
  • Exhibit 11: Global Medical Biosensors Market Segmentation by Application 2013-2018
  • Exhibit 12: Global Medical Biosensors Market Segmentation by Application 2013-2018 (US$ million)
  • Exhibit 13: Global Medical Biosensors Market Segmentation by Technology
  • Exhibit 14: Global Medical Biosensors Market Segmentation by End-user
  • Exhibit 15: Global Medical Biosensors Market Segmentation by End-user 2013
  • Exhibit 16: Global Point-of-Care Testing Market 2013-2018 (US$ million)
  • Exhibit 17: Global Home Diagnostics Market 2013-2018 (US$ million)
  • Exhibit 18: Global Research Laboratories Market 2013-2018 (US$ million)
  • Exhibit 19: Global Medical Biosensors Market Segmentation by End-user 2013-2018
  • Exhibit 20: Global Medical Biosensors Market by Geographical Segmentation 2013
  • Exhibit 21: Global Medical Biosensors Market by Geographical Segmentation 2013-2018
  • Exhibit 22: Medical Biosensors Market in the Americas 2013-2018 (US$ million)
  • Exhibit 23: Medical Biosensors Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 24: Medical Biosensors Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 25: Global Medical Biosensors Market Share Analysis 2013
  • Exhibit 26: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 27: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 28: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 29: Bayer HealthCare: Business Segmentation by Revenue 2013
  • Exhibit 30: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 31: Bayer HealthCare: Geographical Segmentation by Revenue 2013
  • Exhibit 32: LifeScan: Product Segmentation 2013
  • Exhibit 33: LifeScan: Geographical Segmentation by Revenue 2013
  • Exhibit 34: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
  • Exhibit 35: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 36: F. Hoffmann-La Roche: Geographical Segmentation of Pharmaceuticals Division by Revenue 2013
  • Exhibit 37: F. Hoffmann-La Roche: Geographical Segmentation of Diagnostics Division by Revenue 2013
Back to Top